Clinical Trials Sponsored by Alberta Cancer Foundation

Total 3245 results

AHS Cancer Control Alberta
Cross Cancer Institute

Recruiting

Unilateral Neck Radiotherapy in Head and Neck Cancer

Head and Neck Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Unknown

A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce Xerostomia

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours (DCA)

Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence

Sarcoma | Kidney Neoplasms | Testicular Neoplasms | Multiple Myeloma | Ovarian Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer

Prostatic Neoplasms | Neoplasm Metastasis | Palliative Care

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea

Metastatic Colorectal Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer

Prostate Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer (IMRT)

Locally Advanced Cervical Cancer | Integrated MRI Based RT as Standard of Care
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma

Sarcoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation

Prostate Cancer | Osteoporosis

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

Healthy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Hypofractionated Radiotherapy for Small Cell Lung Cancer

Small Cell Carcinoma | Lung Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation

Prostatic Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Evaluating Taste and Smell Function and Food and Taste Preferences of Head and Neck Cancer Patients During Radiation Therapy/Chemotherapy

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin

Colorectal Cancer | Metastasis | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Cone Beam CT Scanning in Lung and Bladder Cancer.

Bladder Carcinoma | Small Cell Carcinoma | Lung Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer

Carcinoma, Small Cell

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide

Glioma | Glioblastoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Trial of Hypofractionated Radiation Therapy for Glioblastoma

Glioblastoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Active, not recruiting

Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014

Neuroendocrine Tumors, NET

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs

Pancreatic Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline

Non-small Cell Lung Cancer | Advanced Solid Malignancies

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)

Head and Neck Neoplasms | Thyroid Neoplasms
AHS Cancer Control Alberta
Cross Cancer Institute

Unknown

Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart

Breast Cancer | Adverse Effect of Radiation Therapy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Unknown

A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers

Glioma | Breast Cancer | Head and Neck Cancer | Carcinoma, Squamous Cell | Prostate Cancer | Carcinoma, Non-Small-Cell-Lung

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Pulse Sequence Development on 3T Magnetic Resonance Imaging/Spectroscopy

Healthy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung Cancer

Extensive Stage Small Cel Lung Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect) (SUPER)

Heart Failure | Renal Cell Carcinoma | Hypertension | Cardiotoxicity

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer Patients

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy

Prostate Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

MVCT Imaging Pilot Study Using Helical Tomotherapy

Cancer, Carcinoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer

Small Cell Carcinoma | Lung Neoplasm

Canada
University of Alberta
Royal Alexandra Hospital; Glenrose Foundation

Not yet recruiting

Exercise Training for Brachial Plexus Injury Following Nerve Transfer

Brachial Plexus Injury

Canada
University of Alberta
Royal Alexandra Hospital; Glenrose Foundation

Completed

Early FES Cycling in Acute Spinal Cord Injury for Neuromuscular Preservation and Neurorecovery

Acute Spinal Cord Injury

Canada
University of Alberta
Canadian Urological Association Scholarship Foundation

Active, not recruiting

18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients

Prostate Cancer

Canada
University of Alberta
The Weston A. Price Foundation

Completed

FMT and Fiber in Patients With Metabolic Syndrome (FMT)

Obesity | Metabolic Syndrome

Canada
University of Alberta
Lotte & John Hecht Memorial Foundation

Completed

Pediatric Integrative Medicine Trial Pilot (PIM)

Pain | Nausea | Vomiting | Anxiety

Canada
University of Alberta
Alberta Health services; Institute of Health Economics, Canada; University Hospital...

Recruiting

Midodrine for the Early Liberation of Vasopressor Support in the ICU (LIBERATE Multi-Site)

Vasoplegia

Canada
University of Alberta
Alberta Heritage Foundation for Medical Research; Institute of Health Economics...

Completed

A Cluster Randomized Trial to Assess the Impact of Opinion Leader Endorsed Evidence Summaries on Improving Quality of Prescribing for Patients With Chronic Cardiovascular Disease

Heart Failure | Coronary Disease | Ischemic Heart Disease

Canada
AHS Cancer Control Alberta
EMD Serono

Active, not recruiting

Avelumab With Valproic Acid in Virus-associated Cancer (LATENT)

Squamous Cell Carcinoma of the Cervix | Cancer That is Associated With a Chronic Viral Infection | p16 Positive SCCHN | p16 Positive Squamous Cell Carcinoma of the Vagina or Vulva | p16 Positive Squamous Cell Carcinoma of the Penis | p16 Positive Squamous Cell Carcinoma of the Anus or Anal... and other conditions

Canada
University of Alberta
Cross Cancer Institute

Active, not recruiting

Decongestive Exercise and Compression for Breast Cancer Related Lymphedema Management (DREAM)

Lymphedema | Breast Neoplasm

Canada
University of Alberta
Cross Cancer Institute

Completed

Manual Therapy and Use of the Dynasplint for Trismus in Patients With Head and Neck Cancer

Trismus | Neoplasms, Head and Neck

Canada
University of Alberta
Cross Cancer Institute

Completed

Therapeutic Resistance Group Exercise Training for Head & Neck Cancer Survivors (TARGET)

Head and Neck Neoplasms | Fatigue | Accessory Nerve Injury

Canada
AHS Cancer Control Alberta
Hologic, Inc.

Completed

Tomosynthesis in Screening Mammography

Breast Density >25%

Canada
M.D. Anderson Cancer Center
Lance Armstrong Foundation

Unknown

Weight Gain Prevention for Breast Cancer Survivors

Breast Cancer

United States
Juravinski Cancer Center
Canadian Breast Cancer Foundation; Juravinski Cancer Centre Foundation

Unknown

Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer (ARTEMIS)

Breast Neoplasm

Canada
University of Alberta
Canadian Institutes of Health Research (CIHR); Alberta Health services; Canadian...

Completed

Point of Care Tests for Syphilis and HIV (PoSH)

Syphilis

Canada
AHS Cancer Control Alberta
Tom Baker Cancer Centre

Recruiting

Study of Niacin in Glioblastoma

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

Canada

Clinical Trials Sponsored by Alberta Cancer Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations